Davis R M Inc Edwards Lifesciences Corp Transaction History

Davis R M Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$61.71 - $77.76 $171,862 - $216,561	2,785 New	2,785 $212,000
Q2 2023 Aug 10, 2023	SELL	$81.41 - $94.33 $71,315 - $82,633	-876 Reduced 23.27%	2,889 $273,000
Q1 2023 May 01, 2023	SELL	$74.26 - $84.51 $1,410 - $1,605	-19 Reduced 0.5%	3,765 $311,000
Q4 2022 Feb 14, 2023	BUY	$68.3 - $87.44 $12,294 - $15,739	180 Added 4.99%	3,784 $282,000
Q3 2022 Nov 08, 2022	BUY	$82.37 - $107.29 $60,047 - $78,214	729 Added 25.36%	3,604 $298,000
Q1 2022 May 05, 2022	BUY	$101.96 - $128.34 $17,843 - $22,459	175 Added 6.48%	2,875 $338,000
Q4 2021 Feb 08, 2022	SELL	$106.37 - $130.68 $6,063 - $7,448	-57 Reduced 2.07%	2,700 $350,000
Q3 2021 Nov 08, 2021	BUY	$102.91 - $122.75 $5,865 - $6,996	57 Added 2.11%	2,757 $312,000
Q2 2021 Aug 12, 2021	SELL	$83.84 - $104.76 $2,012 - $2,514	-24 Reduced 0.88%	2,700 $280,000
Q4 2020 Jan 27, 2021	BUY	$71.69 - $91.23 $195,283 - $248,510	2,724 New	2,724 $249,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Davis R M Inc, based on Form 13F filings with the SEC.

Stay updated on Davis R M Inc with notifications on news.